Key Financial Data Of Group

Chiome Bioscience Inc. - Filing #7270994

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Net sales
780,809,000 JPY
682,464,000 JPY
630,815,000 JPY
712,932,000 JPY
480,853,000 JPY
Ordinary profit (loss)
-1,019,210,000 JPY
-1,217,240,000 JPY
-1,243,838,000 JPY
-1,329,312,000 JPY
-1,291,606,000 JPY
Net assets
1,920,303,000 JPY
1,157,723,000 JPY
1,790,746,000 JPY
1,893,049,000 JPY
3,109,968,000 JPY
Total assets
2,468,857,000 JPY
1,751,454,000 JPY
2,215,470,000 JPY
2,339,439,000 JPY
3,494,554,000 JPY
Net assets per share
28.53
21.66
36.70
45.55
77.99
Basic earnings (loss) per share
-17.54
-24.62
-28.26
-36.74
-36.06
Diluted earnings per share
Equity-to-asset ratio
0.774 xbrli:pure
0.651 xbrli:pure
0.802 xbrli:pure
0.794 xbrli:pure
0.882 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,000,695,000 JPY
-1,069,192,000 JPY
-1,191,009,000 JPY
-1,131,291,000 JPY
-1,360,143,000 JPY
Net cash provided by (used in) investing activities
JPY
173,000 JPY
JPY
-35,384,000 JPY
-3,519,000 JPY
Net cash provided by (used in) financing activities
1,738,421,000 JPY
667,303,000 JPY
1,127,291,000 JPY
271,345,000 JPY
1,944,005,000 JPY
Cash and cash equivalents
2,063,280,000 JPY
1,325,554,000 JPY
1,727,270,000 JPY
1,790,988,000 JPY
2,686,318,000 JPY
Number of employees
47 xbrli:pure
9 xbrli:pure
38 xbrli:pure
51 xbrli:pure
49 xbrli:pure
49 xbrli:pure
42 xbrli:pure
Average number of temporary employees
18 xbrli:pure
4 xbrli:pure
14 xbrli:pure
17 xbrli:pure
14 xbrli:pure
13 xbrli:pure
14 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.